nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display
|
Tang, Jie |
|
2012 |
|
1-2 |
p. 1-11 |
artikel |
2 |
Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating
|
Alshanqiti, Fatimah M. |
|
2017 |
|
1-2 |
p. 23-29 |
artikel |
3 |
A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxin
|
Heveker, Nikolaus |
|
2013 |
|
1-2 |
p. 18-24 |
artikel |
4 |
A molecular case-control study of association of HNF1A gene polymorphisms (rs2259816 and rs7310409) with risk of coronary artery disease in Iranian patients
|
Barzi, Samaneh Adami |
|
2017 |
|
1-2 |
p. 65-70 |
artikel |
5 |
Anti-bacterial specificities in the human fetal B cell repertoire
|
Settmacher, Utz |
|
2013 |
|
1-2 |
p. 91-95 |
artikel |
6 |
Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin
|
O'Boyle, Kevin P. |
|
2013 |
|
1-2 |
p. 25-31 |
artikel |
7 |
Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome
|
Cagan, Murat |
|
|
|
1-2 |
p. 1-8 |
artikel |
8 |
Comparison of expression of a humanized monoclonal antibody in mouse NSO myeloma cells and Chinese Hamster Ovary cells
|
Peakman, Timothy C. |
|
2013 |
|
1-2 |
p. 65-74 |
artikel |
9 |
Conference program
|
|
|
2002 |
|
1-2 |
p. 49-54 |
artikel |
10 |
Conference Program
|
|
|
2008 |
|
1-2 |
p. 38-43 |
artikel |
11 |
Conference program
|
|
|
2008 |
|
1-2 |
p. 61-66 |
artikel |
12 |
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1
|
Major, Joseph G. |
|
2013 |
|
1-2 |
p. 9-17 |
artikel |
13 |
Construction of scFv library of human antibodies against tetanus toxin
|
Nejad, Hamideh Rouhani |
|
2015 |
|
1-2 |
p. 21-26 |
artikel |
14 |
Construction of scFv library of human antibodies against tetanus toxin
|
Nejad, Hamideh Rouhani |
|
2015 |
|
1-2 |
p. 21-26 |
artikel |
15 |
Design and analysis of PCR primers for the amplification and cloning of human immunoglobulin Fab fragments
|
de Boer, Mark |
|
2013 |
|
1-2 |
p. 57-64 |
artikel |
16 |
Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragments
|
Delcommenne, Marc |
|
2012 |
|
1-2 |
p. 29-40 |
artikel |
17 |
Determination of dissociation constants of Anti-ALP monoclonal antibodies by an ELISA – based method
|
Naseri, Mohsen |
|
2015 |
|
1-2 |
p. 1-5 |
artikel |
18 |
Determination of dissociation constants of Anti-ALP monoclonal antibodies by an ELISA – based method
|
Naseri, Mohsen |
|
2015 |
|
1-2 |
p. 1-5 |
artikel |
19 |
Developing and mature human granulocytes express ELP 6 in the cytoplasm
|
Wagner, Lori A. |
|
2013 |
|
1-2 |
p. 21-29 |
artikel |
20 |
Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice
|
Baradaran, Behzad |
|
2009 |
|
1-2 |
p. 11-16 |
artikel |
21 |
Development and characterization of monoclonal antibodies against human IgA in Balb/c mice
|
Ezzatifar, Fatemeh |
|
2015 |
|
1-2 |
p. 7-12 |
artikel |
22 |
Development and characterization of monoclonal antibodies against human IgA in Balb/c mice
|
Ezzatifar, Fatemeh |
|
2015 |
|
1-2 |
p. 7-12 |
artikel |
23 |
Downstream characterization of anti-TNF-α single chain variable fragment antibodies
|
Abdolalizadeh, Jalal |
|
2012 |
|
1-2 |
p. 41-48 |
artikel |
24 |
Epitope analysis of Japanese cedar pollen allergen Cry j2 with a human IgM class monoclonal antibody 404-117
|
Chiba, Seiya |
|
2017 |
|
1-2 |
p. 17-21 |
artikel |
25 |
Erratum
|
|
|
2009 |
|
1-2 |
p. 45 |
artikel |
26 |
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity
|
Koike, Masamichi |
|
2009 |
|
1-2 |
p. 17-27 |
artikel |
27 |
Frequency of viral infections and environmental factors in multiple sclerosis
|
Eftekharian, Mohammad Mahdi |
|
2016 |
|
1-2 |
p. 17-23 |
artikel |
28 |
Future prospects of monoclonal antibodies as magic bullets in Immunotherapy
|
Maleki, Leili Aghebati |
|
2013 |
|
1-2 |
p. 9-13 |
artikel |
29 |
Generation of mouse-human hybridomas secreting human monoclonal antibodies to Japanese cedar pollen allergen Cry j1
|
Yasunori Naganawa |
|
2006 |
|
1-2 |
p. 27-31 |
artikel |
30 |
High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells
|
Dubois, Axel R.S.X. |
|
2016 |
|
1-2 |
p. 1-15 |
artikel |
31 |
Human antibodies targeting CD30^{+} lymphomas
|
Wezler, Xenia |
|
2012 |
|
1-2 |
p. 13-28 |
artikel |
32 |
Humanization of the murine anti-human CD3 monoclonal antibody OKT3
|
Adair, John R. |
|
2013 |
|
1-2 |
p. 41-47 |
artikel |
33 |
Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus
|
Alexander, Hermann |
|
2013 |
|
1-2 |
p. 81-90 |
artikel |
34 |
Human monoclonal antibody 2909 binds to pseudovirions expressing trimers but not monomeric HIV-1 envelope proteins
|
Kimura, Tetsuya |
|
2009 |
|
1-2 |
p. 35-40 |
artikel |
35 |
Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus
|
Bender, Eckhard |
|
2013 |
|
1-2 |
p. 3-8 |
artikel |
36 |
Immunoglobulin G follow-up and immune response longevity analysis in SARS-CoV-2 convalescent patients and vaccinated individuals: A longitudinal analysis
|
Maki, Fadia Mothafar |
|
|
|
1-2 |
p. 19-25 |
artikel |
37 |
Investigation of the correlation between some immune system and biochemical indicators in patients with type 2 diabetes
|
Eftekharian, Mohammad Mahdi |
|
2016 |
|
1-2 |
p. 25-31 |
artikel |
38 |
Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique
|
Aghebati-Maleki, Leili |
|
2017 |
|
1-2 |
p. 57-63 |
artikel |
39 |
Keynotes
|
|
|
2002 |
|
1-2 |
p. 1-2 |
artikel |
40 |
Monoclonal and recombinant antibodies, 30 years after …
|
Emmanuelle Laffly |
|
2006 |
|
1-2 |
p. 33-55 |
artikel |
41 |
Multiple sclerosis and immunological-related risk factors: Results from a case-control study
|
Eftekharian, Mohammad Mahdi |
|
2015 |
|
1-2 |
p. 31-36 |
artikel |
42 |
Multiple sclerosis and immunological-related risk factors: Results from a case-control study
|
Eftekharian, Mohammad Mahdi |
|
2015 |
|
1-2 |
p. 31-36 |
artikel |
43 |
Novel antiphospholipid antibodies in autoimmune bullous diseases
|
Sagi, Lior |
|
2015 |
|
1-2 |
p. 27-30 |
artikel |
44 |
Novel antiphospholipid antibodies in autoimmune bullous diseases
|
Sagi, Lior |
|
2015 |
|
1-2 |
p. 27-30 |
artikel |
45 |
Of patents and patent disputes: The TNFα patent files. Part 1: Humira
|
Storz, Ulrich |
|
2017 |
|
1-2 |
p. 1-16 |
artikel |
46 |
Patterns of dengue virus IgM and IgG antibodies in suspected cases of dengue in Jamaica, 2003–2006
|
Brown, Michelle G. |
|
2009 |
|
1-2 |
p. 29-34 |
artikel |
47 |
Phage surface presentation and secretion of antibody fragments using an adaptable phagemid vector
|
Lah, Maria |
|
2013 |
|
1-2 |
p. 48-56 |
artikel |
48 |
Poster session
|
|
|
2002 |
|
1-2 |
p. 29-48 |
artikel |
49 |
Poster Session
|
|
|
2003 |
|
1-2 |
p. 37-50 |
artikel |
50 |
Poster Session
|
|
|
2004 |
|
1-2 |
p. 41-45 |
artikel |
51 |
Poster session
|
|
|
2006 |
|
1-2 |
p. 41-52 |
artikel |
52 |
Poster Session
|
|
|
2008 |
|
1-2 |
p. 45-60 |
artikel |
53 |
Poster Session
|
|
|
2008 |
|
1-2 |
p. 33-38 |
artikel |
54 |
Postural orthostatic tachycardia syndrome-like symptoms following COVID-19 vaccination: An overview of clinical literature
|
TV, Phu |
|
|
|
1-2 |
p. 9-17 |
artikel |
55 |
Presence of aberrant V_{H}6 domains in anti-interferon-γ autoantibodies in multiple sclerosis
|
Tyumentseva, Marina A. |
|
2013 |
|
1-2 |
p. 31-49 |
artikel |
56 |
Prevalence of tetanus immunity in the Egyptian population
|
Redwan, EL-Rashdy M. |
|
2002 |
|
1-2 |
p. 55-59 |
artikel |
57 |
Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse
|
J. Majidi |
|
2006 |
|
1-2 |
p. 1-5 |
artikel |
58 |
Production and characterization of murine monoclonal antibody against synthetic peptide of CD34
|
Maleki, Leili Aghebati |
|
2013 |
|
1-2 |
p. 1-8 |
artikel |
59 |
Production of IgE antibody to Japanese cedar pollen allergen Cry j1 by short term culture of human peripheral blood lymphocytes
|
Shinmoto, Hiroshi |
|
2009 |
|
1-2 |
p. 41-43 |
artikel |
60 |
Production of monoclonal antibody against alkaline phosphatase
|
M.M. Eftekharian |
|
2006 |
|
1-2 |
p. 17-21 |
artikel |
61 |
Protein microarrays: A new tool for profiling antibody cross-reactivity
|
Paul F. Predki |
|
2006 |
|
1-2 |
p. 7-15 |
artikel |
62 |
Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma
|
Dillman, Susanne L. |
|
2013 |
|
1-2 |
p. 32-40 |
artikel |
63 |
Sensitive antibody-based CTCs detection from peripheral blood
|
Shahneh, Fatemeh Zare |
|
2013 |
|
1-2 |
p. 51-54 |
artikel |
64 |
Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors
|
Tafesse, Tadesse Bekele |
|
2017 |
|
1-2 |
p. 39-55 |
artikel |
65 |
Serum preparation and methods for the large-scale production of IgG monoclonal antibody
|
Zeng, Quing S. |
|
2013 |
|
1-2 |
p. 75-80 |
artikel |
66 |
Session 4: Advances in technologyWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 7-9 |
artikel |
67 |
Session 5: Antibody repertoireTuesday 30th October 2007. Moderator: To be confirmed
|
|
|
2008 |
|
1-2 |
p. 23-24 |
artikel |
68 |
Session 8: Anti-infective, anti-bacterial/viral antibodies: A new emerging paradigm in the field of anti-infectives - I
|
|
|
2006 |
|
1-2 |
p. 37 |
artikel |
69 |
Session 9: Anti-infective, anti-bacterial/viral antibodies: A new emerging paradigm in the field of anti-infectives - II
|
|
|
2006 |
|
1-2 |
p. 39-40 |
artikel |
70 |
Session 7: Applied technologies
|
|
|
2006 |
|
1-2 |
p. 33-36 |
artikel |
71 |
Session 9: Applied technologies - I
|
|
|
2003 |
|
1-2 |
p. 25-26 |
artikel |
72 |
Session 9: Applied technologies - I
|
|
|
2004 |
|
1-2 |
p. 31-32 |
artikel |
73 |
Session 10: Applied technologies - II
|
|
|
2003 |
|
1-2 |
p. 27-35 |
artikel |
74 |
Session 10: Applied technologies - II
|
|
|
2004 |
|
1-2 |
p. 33-37 |
artikel |
75 |
Session 11: Applied technologies - III
|
|
|
2004 |
|
1-2 |
p. 39-40 |
artikel |
76 |
Session 11: Applied technologies IIWednesday 31st October 2007. Moderator: To be confirmed
|
|
|
2008 |
|
1-2 |
p. 37-42 |
artikel |
77 |
Session 10: Applied technologies IWednesday 31st October 2007. Moderator: To be confirmed
|
|
|
2008 |
|
1-2 |
p. 35-36 |
artikel |
78 |
Session 2: Autoimmunity
|
|
|
2002 |
|
1-2 |
p. 9-12 |
artikel |
79 |
Session 5: Autoimmunity
|
|
|
2004 |
|
1-2 |
p. 13-14 |
artikel |
80 |
Session 1: Cancer
|
|
|
2002 |
|
1-2 |
p. 3-7 |
artikel |
81 |
Session 1: Cancer - I
|
|
|
2006 |
|
1-2 |
p. 1-2 |
artikel |
82 |
Session 2: Cancer - I
|
|
|
2003 |
|
1-2 |
p. 3 |
artikel |
83 |
Session 2: Cancer - I
|
|
|
2004 |
|
1-2 |
p. 3-4 |
artikel |
84 |
Session 3: Cancer - II
|
|
|
2003 |
|
1-2 |
p. 5-6 |
artikel |
85 |
Session 2: Cancer - II
|
|
|
2006 |
|
1-2 |
p. 3-8 |
artikel |
86 |
Session 3: Cancer - II
|
|
|
2004 |
|
1-2 |
p. 5-7 |
artikel |
87 |
Session 4: Cancer - III
|
|
|
2003 |
|
1-2 |
p. 7-9 |
artikel |
88 |
Session 4: Cancer - III
|
|
|
2004 |
|
1-2 |
p. 9-11 |
artikel |
89 |
Session 3: Cancer - III
|
|
|
2006 |
|
1-2 |
p. 9-13 |
artikel |
90 |
Session 6: Cancer IIITuesday 30th October 2007. Moderators: To be confirmed
|
|
|
2008 |
|
1-2 |
p. 25-26 |
artikel |
91 |
Session 3: Cancer IIMonday 29th October 2007. Moderators: Peter Vollmers and Kathy Potter
|
|
|
2008 |
|
1-2 |
p. 5-11 |
artikel |
92 |
Session 3: Cancer IIWednesday 12th November 2008. Moderator: H. Peter Vollmers
|
|
|
2008 |
|
1-2 |
p. 5-6 |
artikel |
93 |
Session 2: Cancer IMonday 29th October 2007. Moderators: Zdenka Jonak and Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 3-4 |
artikel |
94 |
Session 2: Cancer IWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 3-4 |
artikel |
95 |
Session 12: Closing plenary lectureWednesday 31st October 2007. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 43 |
artikel |
96 |
Session 3: Emerging technologies
|
|
|
2002 |
|
1-2 |
p. 13-15 |
artikel |
97 |
Session 5: HIVThursday 13th November 2008. Moderator: Mirek Gorny
|
|
|
2008 |
|
1-2 |
p. 11-13 |
artikel |
98 |
Session 7: ImmunomodulationThursday 13th November 2008. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 17-19 |
artikel |
99 |
Session 6: Infectious disease
|
|
|
2006 |
|
1-2 |
p. 29-31 |
artikel |
100 |
Session 8: Infectious diseases
|
|
|
2002 |
|
1-2 |
p. 25-28 |
artikel |
101 |
Session 6: Infectious diseases
|
|
|
2004 |
|
1-2 |
p. 15-19 |
artikel |
102 |
Session 5: Infectious diseases - I
|
|
|
2003 |
|
1-2 |
p. 11-12 |
artikel |
103 |
Session 6: Infectious diseases - II
|
|
|
2003 |
|
1-2 |
p. 13-14 |
artikel |
104 |
Session 9: Infectious diseases IIWednesday 31st October 2007. Moderator: Roberto Burioni
|
|
|
2008 |
|
1-2 |
p. 33-34 |
artikel |
105 |
Session 7: Infectious diseases ITuesday 30th October 2007. Moderator: Alois Lang
|
|
|
2008 |
|
1-2 |
p. 27-29 |
artikel |
106 |
Session 6: Infectious diseasesThursday 13th November 2008. Moderator: Robero Burioni
|
|
|
2008 |
|
1-2 |
p. 15-16 |
artikel |
107 |
Session 4: Molecular biology (I)
|
|
|
2002 |
|
1-2 |
p. 17-18 |
artikel |
108 |
Session 7: Molecular biology - I
|
|
|
2003 |
|
1-2 |
p. 15-19 |
artikel |
109 |
Session 4: Molecular biology - I
|
|
|
2006 |
|
1-2 |
p. 15-17 |
artikel |
110 |
Session 7: Molecular biology - I
|
|
|
2004 |
|
1-2 |
p. 21-25 |
artikel |
111 |
Session 5: Molecular biology (II)
|
|
|
2002 |
|
1-2 |
p. 19-20 |
artikel |
112 |
Session 8: Molecular biology - II
|
|
|
2003 |
|
1-2 |
p. 21-23 |
artikel |
113 |
Session 5: Molecular biology - II
|
|
|
2006 |
|
1-2 |
p. 19-28 |
artikel |
114 |
Session 8: Molecular biology - II
|
|
|
2004 |
|
1-2 |
p. 27-30 |
artikel |
115 |
Session 7: Molecular biology (III)
|
|
|
2002 |
|
1-2 |
p. 21-23 |
artikel |
116 |
Session 8: Molecular biology IITuesday 30th October 2007. Moderator: To be confirmed
|
|
|
2008 |
|
1-2 |
p. 31-32 |
artikel |
117 |
Session 4: Molecular biology IMonday 29th October 2007. Moderators: Jim W. Larrick and Sachdev Sidhu
|
|
|
2008 |
|
1-2 |
p. 13-22 |
artikel |
118 |
Session 10: New approachesFriday 14th November 2008. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 29-31 |
artikel |
119 |
Session 1: Opening plenary session
|
|
|
2004 |
|
1-2 |
p. 1 |
artikel |
120 |
Session 1: Opening plenary session
|
|
|
2003 |
|
1-2 |
p. 1 |
artikel |
121 |
Session 1: Opening plenary sessionMonday 29th October 2007. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 1 |
artikel |
122 |
Session 1: Opening plenary sessionWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008 |
|
1-2 |
p. 1 |
artikel |
123 |
Session 9: Therapeutic antibodies: CancerFriday 14th November 2008. Moderator: Zdenka Jonak
|
|
|
2008 |
|
1-2 |
p. 25-27 |
artikel |
124 |
Session 8: Therapeutic antibodies: InfectionThursday 13th November 2008. Moderator: Alois Lang
|
|
|
2008 |
|
1-2 |
p. 21-23 |
artikel |
125 |
Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian
|
EL-Rashdy M. Redwan |
|
2006 |
|
1-2 |
p. 23-26 |
artikel |
126 |
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor
|
Baradaran, Behzad |
|
2015 |
|
1-2 |
p. 13-20 |
artikel |
127 |
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor
|
Baradaran, Behzad |
|
2015 |
|
1-2 |
p. 13-20 |
artikel |
128 |
The effect of Base Transceiver Station waves on some immunological and hematological factors in exposed persons
|
Taheri, Mohammad |
|
2017 |
|
1-2 |
p. 31-37 |
artikel |
129 |
The pharmacokinetics of ^{131}I-rituximab in a patient with CD20 positive Non-Hodgkin Lymphoma: Evaluation of the effect of radioiodination on the biological properties of rituximab
|
Tran, L. |
|
2011 |
|
1-2 |
p. 37-40 |
artikel |
130 |
Three decades of human monoclonal antibodies: Past, present and future developments
|
Steinitz, Michael |
|
2009 |
|
1-2 |
p. 1-10 |
artikel |
131 |
TRAIL gene expression analysis in multiple sclerosis patients
|
Taheri, Mohammad |
|
2016 |
|
1-2 |
p. 33-38 |
artikel |
132 |
Tumor angiogenesis and anti-angiogenic therapies
|
Shahneh, Fatemeh Zare |
|
2013 |
|
1-2 |
p. 15-19 |
artikel |